The Patent Finder

Terms ending in 2029

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,598,199Octahydropentalene Compounds as Chemokine Receptor Antagonists
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,217,155Metabolites and Derivatives of Ambrisentan
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,648,084Selective Substituted Pyrazine Ligands for Neuronal Nicotinic Receptors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,163,769Antibacterial Compounds
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,188,104Anti-Infective Agents and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,178,548Anti-Infective Agents and Uses Thereof
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,383,658Isoxazole Based Neuronal Nicotinic Receptor Ligands and Methods of Use
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,648,0695-Substituted Indazoles as Kinase Inhibitors
In force
 · Medium confidence
AbbVie Inc.In forceMedium confidence
US 9,365,579Novel Tricyclic Compounds
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US D731,171Template for a Prescription Medicine Container
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
33 more term ends in 2029 · Pro
10 of 43 patents shown. Soonest term end first, then patent number.
Pro members see all 43.
Upgrade to Pro
41 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited